External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home CSCO 2020
Roche and Genentech at

CSCO 2020

September 16 - September 20
Xiamen, China
csco.ac.cn
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
02:00 PM
Duration 15mins Virtual
Safety and patient-reported outcomes (PRO) with atezolizumab (atezo) + bevacizumab (bev) vs sorafenib (sor) in Chinese patients (pts) with unresectable HCC in IMbrave150
Shukui Qin, Zhenggang Ren, Haitao Zhao,Baocheng Wang, Yuxian Bai, Shanzhi Gu, Zhiqiang Meng, Jieer Ying, Baocai Xing, Xianglin Yuan, Lindong Li, Sohail Mulla, Hui Shao, Beiying Ding, Ann-Lii Cheng
Oncology | Gastrointestinal Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.